Neogen Corporation (NEOG) Debt / Equity
- 2026-05-31: Debt/Equity Ratio 0.38.
- 2025-05-31: Debt/Equity Ratio 0.43.
- 2024-05-31: Debt/Equity Ratio 0.28.
- 2024-02-29: Debt/Equity Ratio 0.28.
Complete source-backed debt/equity ratio history.
- Available history
- 2023-08-31 to 2026-05-31
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2026-05-31 | 0.38 |
| 2025-05-31 | 0.43 |
| 2024-05-31 | 0.28 |
| 2024-02-29 | 0.28 |
| 2023-11-30 | 0.28 |
| 2023-08-31 | 0.28 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2026-05-31 | 0.38 |
| 2025-05-31 | 0.43 |
| 2024-05-31 | 0.28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |